Vestiage Promotes Heiser to COO and Board Member

Share Article

Vestiage, a premium anti-aging company specializing in science-based, branded cosmeceuticals and nutraceuticals, announced today that it has promoted Garrett Heiser to Chief Operating Officer and named him to the Board of Directors. Heiser has been with the Company since June of 2012 and was its second employee.

COO Heiser

Without Garrett Heiser, we would not be where we are today.

Vestiage, Inc., a publicly traded anti-aging lifestyle company focused on science-based research and development, sales and marketing of premium branded highly effective anti-aging cosmeceuticals and nutraceuticals, announced today that it promoted Garrett Heiser to Chief Operating Officer and named him to the Board of Directors.

Heiser, 23, has 6 degree's including Business Administration, Economics, Communications, Science and Mathematics, Social and Behavioral Science, Environmental Studies. He also holds a Certificate in Entrepreneurship from U.C. Santa Barbara.

Scott Kimball, CEO of Vestiage, said, "Garrett Heiser was here almost from the inception of this Company, and I can tell you that if it were not for Garrett, we would not be where we are today. Garrett is brilliant and loyal. From the beginning, when I would have an idea, he would just make it happen. It almost didn't matter what I dreamed up, he had the solution. I'm grateful for his loyalty and contribution and I look forward to working with him for a long time. When I was young like Garrett, I often felt held back simply due to my age and it was frustrating. I knew I was smart and on my game, but just because I was young, there was this corporate thing that prevented me from advancing to where I thought I really belonged. At Vestiage, we appreciate the energy, innovation and skills of the young, celebrate them and promote them. We also have people here that are over 60 and we appreciate and reward them for the experience and judgement they bring to the business."

"Vestiage is a Company that is moving so fast and has so much going on that every day is exciting," said Heiser. "It feels like everything you do has a direct impact on the Company."

Vestiage has an active growth plan in place calling for the creation and acquisition of several anti-aging brands over the next 3-5 years. The acquisition program supports and accelerates the Company's organic growth plan. The Vestiage R&D program has resulted in the discovery and/or use of certain patented botanical and marine ingredients, which are then used in novel combinations within its brands. Ingredient research and development, as well as formulations, are done in conjunction with large industry partners and laboratories assisting in the development of internally created brands. The Company's Mergers and Acquisitions team reviews potential acquisition targets regularly. The Company recently completed the acquisition of RegiMEN mens anti-aging system of supplements. Vestiage will launch the female anti-aging line Monterey Bay Nutraceuticals in January 2014 with production giant Robinson Pharma and botanical ingredient company Nutragenesis. The line is designed to address the key issues in high demand for women over 40.

About Vestiage, Inc.
Vestiage is a publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean, and cutting edge botanically based science and ingredients to produce pure, potent, elegantly formulated products with patented ingredients. Using high potency and novel ingredient combinations, Vestiage creates and distributes cosmeceuticals such as Reluma ( and multifunctional nutraceuticals through Monterey Bay Nutraceuticals ( Vestiage brands address the top “in demand” anti-aging consumer concerns. Vestiage research is focused on longevity and human performance science that covers both the cognitive and physical realms. As clinical results validate discoveries, Vestiage intends to apply new potential ingredients or ingredient formulations and combinations to its anti-aging products across brands. To learn more, visit the Company website,

This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forwardlooking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control. Copies of our SEC reports are available upon request from our investor relations department or may be obtained at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Garrett Heiser
Follow us on
Visit website